Antiparkinsonism drugs
問題一覧
1
Idiopathic Parkinsonism, Primary Parkinsonism, Paralysis Agitans
2
Substantia Nigra
3
Parkinsonism.
4
Lewy body
5
PINK1, Parkin, alpha synuclein genes
6
MPP+ exhibits.
7
Tremor at rest
8
Muscle rigidity.
9
Akinesia
10
Bradykinesia
11
Hypokinesia
12
Gait & Postural difficulties
13
Primary parkinsonism
14
Atypical Parkinsonsim
15
Secondary parkinsonism
16
Reserpine
17
Unified parkinson's disease scale.
18
Part 1
19
Stage 1
20
Stage 2
21
Part 2
22
Part 3
23
Part 4
24
Part 5
25
Stage 3
26
Stage 4
27
Stage 5
28
Levodopa
29
Levodopa
30
True
31
Carbidopa
32
Levodopa
33
Carbidopa
34
Amantadine, benztropine, procyclidine, trihexyphenidyl
35
Vitamin B6 pyridoxine
36
Bromocriptine (Parlodel, Provasyn), Pergolide (Permax)
37
Apomorphine (Apokyn), Ropinirole (Requip), Pramipexole (Sifrol)
38
BROMOCRIPTINE, ROTIGOTINE, ROPINIROLE
39
PERGOLIDE
40
PRAMIPEXOLE
41
Bromocriptine (Parlodel)
42
Pergolide (Permax)
43
Pramipexole (Sifrol)
44
Monotherapy in px with mild dse and as a means of smoothing the response to L-dopa
45
Apomorphine (Apokyn)
46
Bromocriptine
47
Pergolide
48
Mao inhibitors, COMT inhibitors
49
Rasagiline
50
Selegiline
51
Tolcapone
52
Entacapone
53
Entacapone, Tolcapone
54
Amantadine symmetrel
55
Amantadine (Symmetrel)
56
Livedo reticularis
57
Anti muscarinic
58
Anti muscarinic
59
PHYSIOLOGIC POSTURAL TREMOR
60
Essential tremor
61
Intentional tremor
62
Rest tremor
63
Tremor
64
B-blockers, Metoprolol, Antiepileptic
65
Huntington’s Disease
66
Tetrabenazine, Reserpine
67
Tourette Syndrome (TS)
68
Haloperidol, Pimozide
69
Restless legs Syndrome
70
Dopaminergic, Ropinirole, Opioid analgesics and BZD
71
Wilson’s Disease
72
Uncontrollable movement
73
Kayser-Fleischer rings)
74
Jaundice
75
Chelating agent, Penicillamine
Cell structure.
Cell structure.
Quinn Karylle Fuentes · 28問 · 2年前Cell structure.
Cell structure.
28問 • 2年前Electrolytes and non electrolytes
Electrolytes and non electrolytes
Quinn Karylle Fuentes · 29問 · 2年前Electrolytes and non electrolytes
Electrolytes and non electrolytes
29問 • 2年前MW
MW
Quinn Karylle Fuentes · 45問 · 2年前MW
MW
45問 • 2年前POST LAB (EXP 4)
POST LAB (EXP 4)
Quinn Karylle Fuentes · 38問 · 2年前POST LAB (EXP 4)
POST LAB (EXP 4)
38問 • 2年前Density and specific gravity
Density and specific gravity
Quinn Karylle Fuentes · 34問 · 2年前Density and specific gravity
Density and specific gravity
34問 • 2年前FORCES OF ATTRACTION
FORCES OF ATTRACTION
Quinn Karylle Fuentes · 18問 · 2年前FORCES OF ATTRACTION
FORCES OF ATTRACTION
18問 • 2年前Microbial growth
Microbial growth
Quinn Karylle Fuentes · 63問 · 2年前Microbial growth
Microbial growth
63問 • 2年前Introduction.
Introduction.
Quinn Karylle Fuentes · 61問 · 2年前Introduction.
Introduction.
61問 • 2年前Microbial control.
Microbial control.
Quinn Karylle Fuentes · 97問 · 2年前Microbial control.
Microbial control.
97問 • 2年前States of matter
States of matter
Quinn Karylle Fuentes · 100問 · 2年前States of matter
States of matter
100問 • 2年前Introduction.
Introduction.
Quinn Karylle Fuentes · 86問 · 2年前Introduction.
Introduction.
86問 • 2年前Drug development.
Drug development.
Quinn Karylle Fuentes · 77問 · 2年前Drug development.
Drug development.
77問 • 2年前CGMP
CGMP
Quinn Karylle Fuentes · 9問 · 2年前CGMP
CGMP
9問 • 2年前Pharmaceutical ingredients.
Pharmaceutical ingredients.
Quinn Karylle Fuentes · 24問 · 2年前Pharmaceutical ingredients.
Pharmaceutical ingredients.
24問 • 2年前Powdered & granules
Powdered & granules
Quinn Karylle Fuentes · 43問 · 2年前Powdered & granules
Powdered & granules
43問 • 2年前Capsule.
Capsule.
Quinn Karylle Fuentes · 24問 · 2年前Capsule.
Capsule.
24問 • 2年前Tablets.
Tablets.
Quinn Karylle Fuentes · 23問 · 2年前Tablets.
Tablets.
23問 • 2年前Calculatiom of dose
Calculatiom of dose
Quinn Karylle Fuentes · 3回閲覧 · 66問 · 2年前Calculatiom of dose
Calculatiom of dose
3回閲覧 • 66問 • 2年前Postlab 5&6
Postlab 5&6
Quinn Karylle Fuentes · 29問 · 2年前Postlab 5&6
Postlab 5&6
29問 • 2年前COLLIGATIVE PROPERTIES.
COLLIGATIVE PROPERTIES.
Quinn Karylle Fuentes · 33問 · 2年前COLLIGATIVE PROPERTIES.
COLLIGATIVE PROPERTIES.
33問 • 2年前SEMI SOLID
SEMI SOLID
Quinn Karylle Fuentes · 69問 · 2年前SEMI SOLID
SEMI SOLID
69問 • 2年前Basic immunology
Basic immunology
Quinn Karylle Fuentes · 60問 · 2年前Basic immunology
Basic immunology
60問 • 2年前Basic immunology (2)
Basic immunology (2)
Quinn Karylle Fuentes · 62問 · 2年前Basic immunology (2)
Basic immunology (2)
62問 • 2年前Transdermal
Transdermal
Quinn Karylle Fuentes · 44問 · 2年前Transdermal
Transdermal
44問 • 2年前Distribution.
Distribution.
Quinn Karylle Fuentes · 43問 · 2年前Distribution.
Distribution.
43問 • 2年前Infectious disease.
Infectious disease.
Quinn Karylle Fuentes · 65問 · 2年前Infectious disease.
Infectious disease.
65問 • 2年前Infectious diseases (2)
Infectious diseases (2)
Quinn Karylle Fuentes · 79問 · 2年前Infectious diseases (2)
Infectious diseases (2)
79問 • 2年前Gram positive ( Bacteriology)
Gram positive ( Bacteriology)
Quinn Karylle Fuentes · 35問 · 2年前Gram positive ( Bacteriology)
Gram positive ( Bacteriology)
35問 • 2年前All topic. ( Compressed.)
All topic. ( Compressed.)
Quinn Karylle Fuentes · 35問 · 2年前All topic. ( Compressed.)
All topic. ( Compressed.)
35問 • 2年前All topic ( Compressed)
All topic ( Compressed)
Quinn Karylle Fuentes · 30問 · 2年前All topic ( Compressed)
All topic ( Compressed)
30問 • 2年前All topics (compressed)
All topics (compressed)
Quinn Karylle Fuentes · 13問 · 2年前All topics (compressed)
All topics (compressed)
13問 • 2年前Exercise 6 ; Isotonic solution.
Exercise 6 ; Isotonic solution.
Quinn Karylle Fuentes · 28問 · 2年前Exercise 6 ; Isotonic solution.
Exercise 6 ; Isotonic solution.
28問 • 2年前Exercise 5 : Buffers.
Exercise 5 : Buffers.
Quinn Karylle Fuentes · 16問 · 2年前Exercise 5 : Buffers.
Exercise 5 : Buffers.
16問 • 2年前Exercise 7 : Factors affecting solubility.
Exercise 7 : Factors affecting solubility.
Quinn Karylle Fuentes · 26問 · 2年前Exercise 7 : Factors affecting solubility.
Exercise 7 : Factors affecting solubility.
26問 • 2年前Experiment 8: Disintegration.
Experiment 8: Disintegration.
Quinn Karylle Fuentes · 23問 · 2年前Experiment 8: Disintegration.
Experiment 8: Disintegration.
23問 • 2年前Experiment 9 ; Interfacial phenomenon and surface tension.
Experiment 9 ; Interfacial phenomenon and surface tension.
Quinn Karylle Fuentes · 35問 · 2年前Experiment 9 ; Interfacial phenomenon and surface tension.
Experiment 9 ; Interfacial phenomenon and surface tension.
35問 • 2年前EXP 9 : Aromatic ammonia spirit.
EXP 9 : Aromatic ammonia spirit.
Quinn Karylle Fuentes · 34問 · 2年前EXP 9 : Aromatic ammonia spirit.
EXP 9 : Aromatic ammonia spirit.
34問 • 2年前EXP 10-11 : CAMPHOR WATER AND CINNAMON WATER.
EXP 10-11 : CAMPHOR WATER AND CINNAMON WATER.
Quinn Karylle Fuentes · 34問 · 2年前EXP 10-11 : CAMPHOR WATER AND CINNAMON WATER.
EXP 10-11 : CAMPHOR WATER AND CINNAMON WATER.
34問 • 2年前EXP 12: ACACIA MUCILAGE
EXP 12: ACACIA MUCILAGE
Quinn Karylle Fuentes · 20問 · 2年前EXP 12: ACACIA MUCILAGE
EXP 12: ACACIA MUCILAGE
20問 • 2年前EXP13&14 : Starch and Barrium sulfate.
EXP13&14 : Starch and Barrium sulfate.
Quinn Karylle Fuentes · 33問 · 2年前EXP13&14 : Starch and Barrium sulfate.
EXP13&14 : Starch and Barrium sulfate.
33問 • 2年前EXP 15 : Liquid petroleum emulsion 1.0
EXP 15 : Liquid petroleum emulsion 1.0
Quinn Karylle Fuentes · 37問 · 2年前EXP 15 : Liquid petroleum emulsion 1.0
EXP 15 : Liquid petroleum emulsion 1.0
37問 • 2年前EXP 15: Liquid petroleum emulsion 1.1
EXP 15: Liquid petroleum emulsion 1.1
Quinn Karylle Fuentes · 23問 · 2年前EXP 15: Liquid petroleum emulsion 1.1
EXP 15: Liquid petroleum emulsion 1.1
23問 • 2年前Enterobacteriaceae
Enterobacteriaceae
Quinn Karylle Fuentes · 35問 · 2年前Enterobacteriaceae
Enterobacteriaceae
35問 • 2年前Enterobacteriaceae.
Enterobacteriaceae.
Quinn Karylle Fuentes · 28問 · 2年前Enterobacteriaceae.
Enterobacteriaceae.
28問 • 2年前LIQUID DOSAGE FORM 1.0
LIQUID DOSAGE FORM 1.0
Quinn Karylle Fuentes · 31問 · 2年前LIQUID DOSAGE FORM 1.0
LIQUID DOSAGE FORM 1.0
31問 • 2年前Liquid dosage form
Liquid dosage form
Quinn Karylle Fuentes · 12問 · 2年前Liquid dosage form
Liquid dosage form
12問 • 2年前MICROMERITICS 1.0
MICROMERITICS 1.0
Quinn Karylle Fuentes · 44問 · 2年前MICROMERITICS 1.0
MICROMERITICS 1.0
44問 • 2年前EXP 7 : ENDOGENOUS AND EXOGENOUS MICROORGANISMS
EXP 7 : ENDOGENOUS AND EXOGENOUS MICROORGANISMS
Quinn Karylle Fuentes · 22問 · 2年前EXP 7 : ENDOGENOUS AND EXOGENOUS MICROORGANISMS
EXP 7 : ENDOGENOUS AND EXOGENOUS MICROORGANISMS
22問 • 2年前EXP 8 : KIRBY-BAUER TECHNIQUE
EXP 8 : KIRBY-BAUER TECHNIQUE
Quinn Karylle Fuentes · 40問 · 2年前EXP 8 : KIRBY-BAUER TECHNIQUE
EXP 8 : KIRBY-BAUER TECHNIQUE
40問 • 2年前EXP 9: STAPHYLOCOCCI
EXP 9: STAPHYLOCOCCI
Quinn Karylle Fuentes · 29問 · 2年前EXP 9: STAPHYLOCOCCI
EXP 9: STAPHYLOCOCCI
29問 • 2年前Drug incompatibilities.
Drug incompatibilities.
Quinn Karylle Fuentes · 41問 · 2年前Drug incompatibilities.
Drug incompatibilities.
41問 • 2年前Drug compatibilities.
Drug compatibilities.
Quinn Karylle Fuentes · 41問 · 2年前Drug compatibilities.
Drug compatibilities.
41問 • 2年前BACTERIOLOGY 3
BACTERIOLOGY 3
Quinn Karylle Fuentes · 35問 · 2年前BACTERIOLOGY 3
BACTERIOLOGY 3
35問 • 2年前BACTERIOLOGY 3
BACTERIOLOGY 3
Quinn Karylle Fuentes · 30問 · 2年前BACTERIOLOGY 3
BACTERIOLOGY 3
30問 • 2年前SUSPENSION.
SUSPENSION.
Quinn Karylle Fuentes · 45問 · 2年前SUSPENSION.
SUSPENSION.
45問 • 2年前Colloidal.
Colloidal.
Quinn Karylle Fuentes · 40問 · 2年前Colloidal.
Colloidal.
40問 • 2年前BACTERIOLOGY 4 (Rickettsia)
BACTERIOLOGY 4 (Rickettsia)
Quinn Karylle Fuentes · 38問 · 2年前BACTERIOLOGY 4 (Rickettsia)
BACTERIOLOGY 4 (Rickettsia)
38問 • 2年前BACTERIOLOGY.
BACTERIOLOGY.
Quinn Karylle Fuentes · 44問 · 2年前BACTERIOLOGY.
BACTERIOLOGY.
44問 • 2年前Emulsion.
Emulsion.
Quinn Karylle Fuentes · 32問 · 2年前Emulsion.
Emulsion.
32問 • 2年前EMULSION
EMULSION
Quinn Karylle Fuentes · 42問 · 2年前EMULSION
EMULSION
42問 • 2年前MEDICAL RELATED PROBLEMS.
MEDICAL RELATED PROBLEMS.
Quinn Karylle Fuentes · 36問 · 2年前MEDICAL RELATED PROBLEMS.
MEDICAL RELATED PROBLEMS.
36問 • 2年前MEDICATION RELATED PROBLEMS.
MEDICATION RELATED PROBLEMS.
Quinn Karylle Fuentes · 33問 · 2年前MEDICATION RELATED PROBLEMS.
MEDICATION RELATED PROBLEMS.
33問 • 2年前Mycology.
Mycology.
Quinn Karylle Fuentes · 30問 · 2年前Mycology.
Mycology.
30問 • 2年前Mycology 2.0
Mycology 2.0
Quinn Karylle Fuentes · 34問 · 2年前Mycology 2.0
Mycology 2.0
34問 • 2年前m
m
Quinn Karylle Fuentes · 15問 · 2年前m
m
15問 • 2年前ppr
ppr
Quinn Karylle Fuentes · 25問 · 2年前ppr
ppr
25問 • 2年前MEDICAL DEVICES.
MEDICAL DEVICES.
Quinn Karylle Fuentes · 20問 · 2年前MEDICAL DEVICES.
MEDICAL DEVICES.
20問 • 2年前Pharmacokinetics. (1.0)
Pharmacokinetics. (1.0)
Quinn Karylle Fuentes · 86問 · 2年前Pharmacokinetics. (1.0)
Pharmacokinetics. (1.0)
86問 • 2年前Pharmacokinetics (1.1)
Pharmacokinetics (1.1)
Quinn Karylle Fuentes · 100問 · 2年前Pharmacokinetics (1.1)
Pharmacokinetics (1.1)
100問 • 2年前Pharmacokinetics (1.2)
Pharmacokinetics (1.2)
Quinn Karylle Fuentes · 19問 · 2年前Pharmacokinetics (1.2)
Pharmacokinetics (1.2)
19問 • 2年前Introduction.
Introduction.
Quinn Karylle Fuentes · 17問 · 2年前Introduction.
Introduction.
17問 • 2年前Introduction of biochemistry
Introduction of biochemistry
Quinn Karylle Fuentes · 76問 · 2年前Introduction of biochemistry
Introduction of biochemistry
76問 • 2年前Intro medicanal chemistry.
Intro medicanal chemistry.
Quinn Karylle Fuentes · 56問 · 2年前Intro medicanal chemistry.
Intro medicanal chemistry.
56問 • 2年前Carbohydrates
Carbohydrates
Quinn Karylle Fuentes · 75問 · 2年前Carbohydrates
Carbohydrates
75問 • 2年前Carbohydrates 1.1
Carbohydrates 1.1
Quinn Karylle Fuentes · 31問 · 2年前Carbohydrates 1.1
Carbohydrates 1.1
31問 • 2年前Detect and quality variation.
Detect and quality variation.
Quinn Karylle Fuentes · 56問 · 2年前Detect and quality variation.
Detect and quality variation.
56問 • 2年前INTRODUCTION
INTRODUCTION
Quinn Karylle Fuentes · 98問 · 2年前INTRODUCTION
INTRODUCTION
98問 • 2年前lab (1-2)
lab (1-2)
Quinn Karylle Fuentes · 15問 · 2年前lab (1-2)
lab (1-2)
15問 • 2年前lab 1-2
lab 1-2
Quinn Karylle Fuentes · 14問 · 2年前lab 1-2
lab 1-2
14問 • 2年前Pharmaceutical chemistry.
Pharmaceutical chemistry.
Quinn Karylle Fuentes · 45問 · 2年前Pharmaceutical chemistry.
Pharmaceutical chemistry.
45問 • 2年前Pharmaceutical chemistry 1.1
Pharmaceutical chemistry 1.1
Quinn Karylle Fuentes · 35問 · 2年前Pharmaceutical chemistry 1.1
Pharmaceutical chemistry 1.1
35問 • 2年前Unit 3.
Unit 3.
Quinn Karylle Fuentes · 39問 · 2年前Unit 3.
Unit 3.
39問 • 2年前Histamin and kinins
Histamin and kinins
Quinn Karylle Fuentes · 70問 · 2年前Histamin and kinins
Histamin and kinins
70問 • 2年前PUD.
PUD.
Quinn Karylle Fuentes · 45問 · 2年前PUD.
PUD.
45問 • 2年前..
..
Quinn Karylle Fuentes · 61問 · 2年前..
..
61問 • 2年前Lipids.
Lipids.
Quinn Karylle Fuentes · 67問 · 2年前Lipids.
Lipids.
67問 • 2年前lipids.
lipids.
Quinn Karylle Fuentes · 71問 · 2年前lipids.
lipids.
71問 • 2年前LAB ✨
LAB ✨
Quinn Karylle Fuentes · 93問 · 2年前LAB ✨
LAB ✨
93問 • 2年前Drug discovery.
Drug discovery.
Quinn Karylle Fuentes · 87問 · 2年前Drug discovery.
Drug discovery.
87問 • 2年前disease of lipids.
disease of lipids.
Quinn Karylle Fuentes · 13問 · 2年前disease of lipids.
disease of lipids.
13問 • 2年前Intro (identify structure)
Intro (identify structure)
Quinn Karylle Fuentes · 57問 · 2年前Intro (identify structure)
Intro (identify structure)
57問 • 2年前Carbohydrates
Carbohydrates
Quinn Karylle Fuentes · 98問 · 2年前Carbohydrates
Carbohydrates
98問 • 2年前Dynamic.
Dynamic.
Quinn Karylle Fuentes · 96問 · 2年前Dynamic.
Dynamic.
96問 • 2年前Unit 1
Unit 1
Quinn Karylle Fuentes · 32問 · 2年前Unit 1
Unit 1
32問 • 2年前問題一覧
1
Idiopathic Parkinsonism, Primary Parkinsonism, Paralysis Agitans
2
Substantia Nigra
3
Parkinsonism.
4
Lewy body
5
PINK1, Parkin, alpha synuclein genes
6
MPP+ exhibits.
7
Tremor at rest
8
Muscle rigidity.
9
Akinesia
10
Bradykinesia
11
Hypokinesia
12
Gait & Postural difficulties
13
Primary parkinsonism
14
Atypical Parkinsonsim
15
Secondary parkinsonism
16
Reserpine
17
Unified parkinson's disease scale.
18
Part 1
19
Stage 1
20
Stage 2
21
Part 2
22
Part 3
23
Part 4
24
Part 5
25
Stage 3
26
Stage 4
27
Stage 5
28
Levodopa
29
Levodopa
30
True
31
Carbidopa
32
Levodopa
33
Carbidopa
34
Amantadine, benztropine, procyclidine, trihexyphenidyl
35
Vitamin B6 pyridoxine
36
Bromocriptine (Parlodel, Provasyn), Pergolide (Permax)
37
Apomorphine (Apokyn), Ropinirole (Requip), Pramipexole (Sifrol)
38
BROMOCRIPTINE, ROTIGOTINE, ROPINIROLE
39
PERGOLIDE
40
PRAMIPEXOLE
41
Bromocriptine (Parlodel)
42
Pergolide (Permax)
43
Pramipexole (Sifrol)
44
Monotherapy in px with mild dse and as a means of smoothing the response to L-dopa
45
Apomorphine (Apokyn)
46
Bromocriptine
47
Pergolide
48
Mao inhibitors, COMT inhibitors
49
Rasagiline
50
Selegiline
51
Tolcapone
52
Entacapone
53
Entacapone, Tolcapone
54
Amantadine symmetrel
55
Amantadine (Symmetrel)
56
Livedo reticularis
57
Anti muscarinic
58
Anti muscarinic
59
PHYSIOLOGIC POSTURAL TREMOR
60
Essential tremor
61
Intentional tremor
62
Rest tremor
63
Tremor
64
B-blockers, Metoprolol, Antiepileptic
65
Huntington’s Disease
66
Tetrabenazine, Reserpine
67
Tourette Syndrome (TS)
68
Haloperidol, Pimozide
69
Restless legs Syndrome
70
Dopaminergic, Ropinirole, Opioid analgesics and BZD
71
Wilson’s Disease
72
Uncontrollable movement
73
Kayser-Fleischer rings)
74
Jaundice
75
Chelating agent, Penicillamine